Case Studies

Researchers at Western University are working with a global animal health company to repurpose a test initially developed for humans

The University of Southern Denmark joined IN-PART in 2019 and have experienced valuable engagement from our global R&D network.

Portland State University’s Innovation & Intellectual Property Team have entered a collaboration with a world-leading speciality chemicals and performance coatings company

The University of Nottingham is working with a UK-based life sciences company to test a new cancer-detection technology from Nottingham scientists

Dr. Qing Liu-Michael, Program Director at USC's Eli and Edythe Broad Center, has found new routes to industry engagement through IN-PART's Discover service

Discover Case Study: A pharma company has established collaborations with universities across Europe and North America after a successful Discover campaign

The University of Hertfordshire has secured ICURe funding to develop and commercialise a new energy harvesting technology

Early in 2019, the commercialisation office at North Carolina State University had to decide whether to take ownership of a group of vaccine patents

The Medical University of Vienna, one of the world's largest and most renowned medical universities, joined IN-PART in January 2018.

The collaboration will enable ECO to further develop, register and commercialise a clostridium perfringens vaccine for the poultry industry

A global pharmaceutical company from Germany have funded collaborative research with Newcastle to triage proprietary compounds for the treatment of fibrosis

Oxford and Axol have secured funding from the BBSRC to create models of the human cerebellum from human iPSCs to investigate the development of neurological diseases

After an initial introduction through IN-PART, Northeastern University CRI have established a long-term partnership with a global biopharma company

Shortly after posting their technology on IN-PART, the TTO at GWU were approached by an environmental products developer to discuss collaborations

Since making the initial connection on IN-PART, researchers at the materials company have conducted a proof-of-concept trial and are now evaluating the results

The University of Nottingham are re-evaluating their position on a hPSC technology after a conversation with an company through IN-PART

Constructive feedback from a first match informed conversations with a second match, leading to a partnership to co-develop the therapy

A little over six months ago, IN-PART matched a global life science company to a technology being developed by scientists at the University of Tennessee

Since joining IN-PART 3 years ago, UPenn has received significant interest from our network of R&D professionals looking to collaborate with cutting-edge research

Since their arrival to the platform, University Health Network have received a number of introduction requests and qualified feedback from IN-PART’s global network of R&D decision-makers

Over the past year, innovation being developed by researchers at Fox Chase Cancer Centre has been matched to a number of new industry partners on IN-PART

On the day that the Director of R&D at Mark’ennovy gained access to IN-PART, he received a match...

IN-PART’s team paired the two, providing Innoture with a direct introduction to the relevant point of contact at the university

The University of York used IN-PART's matchmaking platform to find new industry partners and to evaluate their portfolio through feedback, engagement metrics, and impact reports

The University of Manchester has had a number of successful interactions with world-leading companies in the pharmaceutical and biotech sectors since joining IN-PART

Brunel University was matched to TBG Solutions through IN-PART's matchmaking platform. The two are now exploring multiple routes of collaboration across a range of Brunel's technologies

After posting a fuzzy logic technology on IN-PART, Essex are now in progressive discussions about a potential license with a new industry partner

After receiving several introduction requests from senior-level R&D professionals through IN-PART, one technology gained particular interest...

A member of a medical device company contacted Bristol through IN-PART, resulting in the lead academic meeting with the company to discuss potential collaborations under NDA

Soon after submitting an opportunity to IN-PART, Aberystwyth signed an MTA with a consumer goods company to test some materials being developed at the university